XML 34 R25.htm IDEA: XBRL DOCUMENT
v3.22.1

Investments (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2022
Equity Method Investments and Joint Ventures [Abstract] |
Schedule Of Investments | Equity investments by measurement category were as follows (in thousands):
Measurement category | March 31, 2022 |  | June 30, 2021
Fair value | $ | 17,842 |  |  | $ | 29,084 |
Measurement alternative | 38,180 |  |  | 23,002 |
Equity method | 12,477 |  |  | 17,154 |
Total | $ | 68,499 |  |  | $ | 69,240 |
Schedule Of Changes In Equity Investments | The following tables show a reconciliation of the changes in our equity investments (in thousands):
| Nine Months Ended March 31, 2022
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 23,002 |  |  | $ | 29,084 |  |  | $ | 17,154 |  |  | $ | 69,240 |
Net additions (reductions) to investments (1) | 7,665 |  |  | (3,202) |  |  | 1,250 |  |  | 5,713 |
Observable price adjustments on non-marketable equity securities | 5,367 |  |  | — |  |  | — |  |  | 5,367 |
Unrealized losses on marketable equity securities | — |  |  | (9,666) |  |  | — |  |  | (9,666) |
Realized gains on marketable and non-marketable equity securities | 2,355 |  |  | 1,626 |  |  | — |  |  | 3,981 |
Impairment of investments | (209) |  |  | — |  |  | — |  |  | (209) |
Loss attributable to equity method investments | — |  |  | — |  |  | (5,927) |  |  | (5,927) |
Carrying value at the end of the period | $ | 38,180 |  |  | $ | 17,842 |  |  | $ | 12,477 |  |  | $ | 68,499 |
(1)Net additions (reductions) to investments includes additions from purchases, reductions due to exits of securities, or reclassifications due to our acquisition of an investee in which we held a prior equity interest.
| Nine Months Ended March 31, 2021
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 30,033 |  |  | $ | — |  |  | $ | 14,109 |  |  | $ | 44,142 |
Additions to investments | 2,538 |  |  | 5,000 |  |  | 12,500 |  |  | 20,038 |
Observable price adjustments on non-marketable equity securities | 1,000 |  |  | — |  |  | — |  |  | 1,000 |
Unrealized gains on marketable equity securities | — |  |  | 8,442 |  |  | — |  |  | 8,442 |
Reclassifications (2) | (10,569) |  |  | 10,569 |  |  | — |  |  | — |
Loss attributable to equity method investments | — |  |  | — |  |  | (9,895) |  |  | (9,895) |
Carrying value at the end of the period | $ | 23,002 |  |  | $ | 24,011 |  |  | $ | 16,714 |  |  | $ | 63,727 |
(2)During the nine months ended March 31, 2021, one of our investments, which was previously accounted for under the measurement alternative, completed its initial public offering which resulted in a change of accounting methodology to fair value.

X
- Definition Schedule Of Changes In Equity Investments [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfChangesInEquityInvestmentsTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Investments [Table Text Block] + References No definition available. + Details
Name: | rmd_ScheduleOfInvestmentsTableTextBlock
Namespace Prefix: | rmd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration